Less frequent glatiramer acetate (Copaxone)

People who took the three times a week version of Copaxone for three years did better than those who were in the placebo group for the first year of the trial. Presented at the American Academy of Neurology (AAN) meeting. MPR Glatiramer acetate (Copaxone) - A to Z of MS
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news